Literature DB >> 19844239

Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study.

Fernando A Bozza1, Philippe Garteiser, Marcus F Oliveira, Sabrina Doblas, Rebecca Cranford, Debra Saunders, Inna Jones, Rheal A Towner, Hugo C Castro-Faria-Neto.   

Abstract

Brain dysfunction is frequently observed in sepsis as a consequence of changes in cerebral structure and metabolism, resulting in worse outcome and reduced life-quality of surviving patients. However, the mechanisms of sepsis-associated encephalopathy development and a better characterization of this syndrome in vivo are lacking. Here, we used magnetic resonance imaging (MRI) techniques to assess brain morphology and metabolism in a murine sepsis model (cecal ligation and puncture, CLP). Sham-operated and CLP mice were subjected to a complete MRI session at baseline, 6 and 24 h after surgery. Accumulation of vasogenic edematic fluid at the base of the brain was observed in T(2)-weighted image at 6 and 24 h after CLP. Also, the water apparent diffusion coefficients in both hippocampus and cortex were decreased, suggesting a cytotoxic edema in brains of nonsurvival septic animals. Moreover, the N-acetylaspartate/choline ratio was reduced in brains of septic mice, indicating neuronal damage. In conclusion, noninvasive assessment by MRI allowed the identification of new aspects of brain damage in sepsis, including cytotoxic and vasogenic edema as well as neuronal damage. These findings highlight the potential applications of MRI techniques for the diagnostic and therapeutic studies in sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844239      PMCID: PMC2949132          DOI: 10.1038/jcbfm.2009.215

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

Review 1.  Magnetic resonance spectroscopy of the human brain.

Authors:  B Ross; S Bluml
Journal:  Anat Rec       Date:  2001-04

2.  Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.

Authors:  D G Remick; D E Newcomb; G L Bolgos; D R Call
Journal:  Shock       Date:  2000-02       Impact factor: 3.454

Review 3.  Pathophysiology of septic encephalopathy: a review.

Authors:  M C Papadopoulos; D C Davies; R F Moss; D Tighe; E D Bennett
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

Review 4.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

5.  Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Authors:  E Wesley Ely; Ayumi Shintani; Brenda Truman; Theodore Speroff; Sharon M Gordon; Frank E Harrell; Sharon K Inouye; Gordon R Bernard; Robert S Dittus
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

6.  Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock.

Authors:  Tarek Sharshar; Francoise Gray; Geoffroy Lorin de la Grandmaison; Nicholas S Hopkinson; Ewen Ross; Anne Dorandeu; David Orlikowski; Jean-Claude Raphael; Philippe Gajdos; Djillali Annane
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

7.  Transgenic mice expressing human copper-zinc superoxide dismutase exhibit attenuated apparent diffusion coefficient reduction during reperfusion following focal cerebral ischemia.

Authors:  Yasuaki Kokubo; Gerald B Matson; Nikita Derugin; Tony Hill; Anthony Mancuso; Pak H Chan; Philip R Weinstein
Journal:  Brain Res       Date:  2002-08-23       Impact factor: 3.252

8.  Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI.

Authors:  Paul M Walker; Douraïed Ben Salem; Alain Lalande; Maurice Giroud; François Brunotte
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

9.  Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.

Authors:  Kim Vuori; Leena Kankaanranta; Anna-Maija Häkkinen; Eija Gaily; Leena Valanne; Marja-Liisa Granström; Heikki Joensuu; Göran Blomstedt; Anders Paetau; Nina Lundbom
Journal:  Radiology       Date:  2004-01-22       Impact factor: 11.105

10.  The neuropathology of septic shock.

Authors:  Tarek Sharshar; Djillali Annane; Geoffroy Lorin de la Grandmaison; Jean Philippe Brouland; Nicholas S Hopkinson; Gray Françoise
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

View more
  34 in total

Review 1.  The intensive care delirium research agenda: a multinational, interprofessional perspective.

Authors:  Pratik P Pandharipande; E Wesley Ely; Rakesh C Arora; Michele C Balas; Malaz A Boustani; Gabriel Heras La Calle; Colm Cunningham; John W Devlin; Julius Elefante; Jin H Han; Alasdair M MacLullich; José R Maldonado; Alessandro Morandi; Dale M Needham; Valerie J Page; Louise Rose; Jorge I F Salluh; Tarek Sharshar; Yahya Shehabi; Yoanna Skrobik; Arjen J C Slooter; Heidi A B Smith
Journal:  Intensive Care Med       Date:  2017-06-13       Impact factor: 17.440

Review 2.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

3.  Caspase-3 mediates in part hippocampal apoptosis in sepsis.

Authors:  Clarissa M Comim; Tatiana Barichello; Denis Grandgirard; Felipe Dal-Pizzol; João Quevedo; Stephen L Leib
Journal:  Mol Neurobiol       Date:  2012-10-11       Impact factor: 5.590

4.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

5.  High Frequency of Neuroimaging Abnormalities Among Pediatric Patients With Sepsis Who Undergo Neuroimaging.

Authors:  Mary K Sandquist; Mark S Clee; Smruti K Patel; Kelli A Howard; Toni Yunger; Usha D Nagaraj; Blaise V Jones; Lin Fei; Sudhakar Vadivelu; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2017-07       Impact factor: 3.624

6.  Murine model to study brain, behavior and immunity during hepatic encephalopathy.

Authors:  Lindisley Ferreira Gomides; Pedro Elias Marques; Bruno Engler Faleiros; Rafaela Vaz Pereira; Sylvia Stella Amaral; Thais Reis Lage; Gustavo Henrique Souza Resende; Patricia Alves Maia Guidine; Giselle Foureaux; Fabíola Mara Ribeiro; Fabiana Paiva Martins; Marco Antônio Peliky Fontes; Anderson José Ferreira; Remo Castro Russo; Mauro Martins Teixeira; Márcio Flávio Moraes; Antonio Lúcio Teixeira; Gustavo Batista Menezes
Journal:  World J Hepatol       Date:  2014-04-27

Review 7.  Neuroimaging after critical illness: implications for neurorehabilitation outcome.

Authors:  Ramona O Hopkins; James C Jackson
Journal:  NeuroRehabilitation       Date:  2012       Impact factor: 2.138

8.  Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock.

Authors:  Herbert Spapen; Duc Nam Nguyen; Joris Troubleyn; Luc Huyghens; Johan Schiettecatte
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

Review 9.  Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2012-12-05       Impact factor: 3.584

10.  Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy.

Authors:  Jing Wu; Mingqiang Zhang; Shuangying Hao; Ming Jia; Muhuo Ji; Lili Qiu; Xiaoyan Sun; Jianjun Yang; Kuanyu Li
Journal:  Mol Neurobiol       Date:  2014-10-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.